Suresh Krishnan
Pain Medicine · Troy, MONPI 1760598668
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,310 of the $9,823 with a category attached, or 64.2%. 35 manufacturers reported payments, led by Spinal Simplicity, LLC at 24.8% of the total. Reporting peaked in 2019 at $3,348 and has fallen 91.7% since, to $277 in 2025.
Across 238 payments — averaging $41.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$2K
- Abbott$2K
- Medtronic$2K
- Vertiflex, Inc.$1K
- AbbVie$401
- Nevro Corp.$392
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1,90019%
- Food & beverage$6,31064%
- Education$1,61316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 5 | $2,432 |
| Abbott | 46 | $1,857 |
| Medtronic(2 entities) | 56 | $1,628 |
| Vertiflex, Inc. | 8 | $1,059 |
| AbbVie(2 entities) | 23 | $401 |
| Nevro Corp. | 15 | $392 |
| Tersera Therapeutics LLC | 11 | $233 |
| Scilex Pharmaceuticals Inc. | 10 | $218 |
| Collegium Pharmaceutical, Inc. | 10 | $147 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $145 |
| Boston Scientific | 5 | $125 |
| Galderma Laboratories, L.p. | 1 | $125 |
| Pfizer | 7 | $110 |
| SPR Therapeutics, Inc | 1 | $109 |
| Averitas Pharma Inc. | 1 | $105 |
| GRT US Holding, Inc. | 1 | $87 |
| Vertos Medical, Inc. | 5 | $64 |
| Stimwave Technologies Incorporated | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Nalu Medical, Inc. | 1 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Kaleo, Inc. | 1 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Valinor Pharma, LLC | 2 | $35 |
| IBSA Pharma Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Stryker | 1 | $29 |
| Orthogenrx Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Impel Pharmaceuticals Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$2,432
- Proclaim Family of SCS IPGs$825
- Superion ISS$703
- INTELLIS ADAPTIVESTIM$410
- INTELLIS$230
- Omnia$150
- RESTORE$145
- PROCLAIM$137
- RELISTOR$128
- SYNCHROMED$121
- SPRINT PNS System$109
- Qutenza$105
How this compares
$9,823 in reported general payments places this provider in the 80th percentile of 124 pain medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 11 | $2,293 |
| Gabapentin | 42 | $594 |
| Ibuprofen | 13 | $101 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Troy
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
- Chad SheltonSaint Peters$18K
- Katharine GurbaSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.